NOT-CA-19-024: Notice of Change to Award Information in RFA-CA-19-032 "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)"

Notice of Change to Award Information in RFA-CA-19-032 "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)"

Notice Number: NOT-CA-19-024

Key Dates
Release Date:January 31, 2019

Related Announcements
RFA-CA-19-032

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct and clarify the Award Information in RFA-CA-19-032 "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)".

The following section of RFA-CA-19-032 has been corrected:

Part 2. Full Text of Announcement, Section II. Award Information

Funds Available and Anticipated Number of Awards

Currently reads:

NCI intends to commit $4,000,000 in FY 2021 to fund 6-8 awards.

Should correctly read (in italics):

Funds Available and Anticipated Number of Awards:

NCI intends to commit $4,000,000 in FY 2020 and $4,000,000 in FY 2021 to fund 5-6 awards for each application due date.

Inquiries

Please direct all inquiries to:

Elizabeth L. Read-Connole, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6190
Email: bconnole@mail.nih.gov

Financial/Grants Management Contact(s)

Mutema Nyankale
National Cancer Institute (NCI)
Telephone: 240-276-5987
Email: nyankalem@mail.nih.gov